Vaccines

15 Mar 2010 Vacc-C5 to be prepared for phase I/II clinical trial
15 Mar 2010 Initiation of Two Phase II Studies with Ipsen's Proprietary BIM 23A760 First-in-Class Chimeric Compound in the Treatment of Acromegaly and Carcinoid Syndrome Due to Neuroendocrine Tumors
12 Mar 2010 Baxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu Vaccine
11 Mar 2010 BioSante Announces Positive Leukemia Vaccine Results
10 Mar 2010 ImmunoCellular Therapeutics’ Dendritic Cell-Based Vaccine Demonstrates Statistically Significant Increase in Survival in an Animal Model of Glioblastoma
09 Mar 2010 Bavarian Nordic Successfully Completes End of Phase II Meeting for PROSTVAC
08 Mar 2010 Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis™ Personalized Immunotherapy Platform in Metastatic RCC at ASCO GU Symposium
04 Mar 2010 Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
04 Mar 2010 BioVex Initiates Phase 1 Clinical Trial with Its Genital Herpes Vaccine, ImmunoVEXHSV2
03 Mar 2010 Merck Reports Results of Phase III Study of Investigational Oral Allergy Immunotherapy Tablet (AIT) in Patients Ages 5-17 with Grass Pollen Allergy
25 Feb 2010 AFFiRiS AG: vaccination against hypertension is development project no. 4 and has already been awarded an FFG grant of up to 1.2 million.
24 Feb 2010 Pfizer Receives FDA Approval for Prevnar 13 for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
24 Feb 2010 Publication of Vical's H5N1 Results Paves the Way for H1N1 Clinical Trial
23 Feb 2010 GlycoVaxyn's First Clinical Study with Bioconjugate Vaccine Initiated
22 Feb 2010 Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers
22 Feb 2010 CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
22 Feb 2010 Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease
19 Feb 2010 Sanofi Pasteur’s A(H1N1) Vaccine Humenza Recommended by European Medicines Agency
19 Feb 2010 NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
18 Feb 2010 VIRxSYS Announces at CROI Promising Results from Its HIV Vaccine Study
18 Feb 2010 GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
17 Feb 2010 Immune Targeting Systems (ITS) Ltd. Secures an GBP 8.65 mln Series A Extension to Fund FP-01, Its Synthetic Universal Flu Vaccine Through Phase-II Studies
17 Feb 2010 In Phase III Data Merck's GARDASIL® Was Efficacious Against Anal Disease Caused by HPV 6,11,16, and 18
12 Feb 2010 Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
11 Feb 2010 Intercell obtains results from its first Phase I investigational vaccine study for Streptococcus pneumoniae

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top